SCHEMBL5747715

SCHEMBL5747715

CCOC(=O)/C(O)=C/c1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.54
MEN1 O00255 5/20 0.54
MAPT P10636 7/20 0.53
LMNA P02545 5/20 0.53
ALDH1A1 P00352 4/20 0.53
NPSR1 Q6W5P4 3/20 0.53
GAA P10253 2/20 0.53
RAB9A P51151 2/20 0.53
GPR55 Q9Y2T6 2/20 0.53
HPGD P15428 2/20 0.53
HSP90AA1 P07900 1/20 0.53
HTT P42858 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.50
POLB P06746 1/20 0.47
CYP19A1 P11511 1/20 0.46
CYP11B2 P19099 1/20 0.46
TBXAS1 P24557 3/20 0.45
MAPK1 P28482 3/20 0.44
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5747718 1.00 KMT2A (0.54) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL11784300 0.86 MEN1 (0.63) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL2420056 0.85 MAPT (0.53) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL2420053 0.85 MAPT (0.53) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL27224519 0.84 TBXAS1 (0.49) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL8388743 0.84 MAPT (0.49) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL5745572 0.83 MAPT (0.65) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL5745570 0.83 MAPT (0.65) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL7392168 0.83 MEN1 (0.59) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL7392171 0.83 MEN1 (0.59) KMT2AMEN1MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664040-A1 GYRASE INHIBITORS PFIZER INC. (US) 2006-06-07 EP disclosed
US-6984652-B2 Gyrase inhibitors WARNER-LAMBERT COMPANY LLC (US) 2006-01-10 US disclosed
US-20050250823-A1 Gyrase inhibitors YAGER KRAIG 2005-11-10 US disclosed
WO-2005026162-A1 GYRASE INHIBITORS PFIZER INC. (US) 2005-03-24 WO disclosed
US-20050054697-A1 Gyrase inhibitors PFIZER INC. 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054697-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B KMT2A 3223/4885MEN1 3349/4885MAPT 3874/4885
US-20050250823-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B KMT2A 3223/4885MEN1 3349/4885MAPT 3874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.